SI-BONE Corp - SIBN Short-Term Debt to Capital
The market trend for the specific short-term debt-to-equity ratio of SI-BONE, Inc. (SIBN) is fixed at 0.00. SI-BONE, Inc. (SIBN) is developing innovative pelvic fixation systems that are rapidly replacing outdated methodologies. The business relies on significant pricing power and stable demand for its unique iFuse implants. However, geopolitical tensions and sanctions are hindering product deliveries to several closed regions.
Analytical breakdowns for SI-BONE, Inc.
The logistics precision of SI-BONE (SIBN) sterile bone implants requires stable funding of operating cycles to prevent disruptions in surgical schedules. An analysis of the ratio between current liabilities under one year and equity allows for an assessment of the company's reliance on short-term borrowings relative to its own capital, where low values confirm financial stability and a high degree of market confidence in the issuer's liability structure.